Jon, with regard to my comments today on IRB, this is the chain of events leading to what I stated.
March 21 conference call "This lead clinical partner has nearly completed approval work on it's university's institutional review board, which has not raised any significant issues, and we expect their final approval within about two weeks."
When that time period more than went by, poster Interstate received the following mail from Rabin.
April 8 "The lead clinic has an IRB board meeting to approve the trial end of next week. They had some kind of scheduling issue. We can't announce the agreement and post on clinicaltrials.gov until they get formal board approval. Soon!" http://investorshub.advfn.com/boards/read_msg.aspx?message_id=61863211
That meeting would have been April 14-15. If approved, trial data would have appeared on clinicaltrials.gov in approx. 2-5 days. Nothing to date on the site. All of the above were what my comments were based on.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.